These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1279206)

  • 1. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
    Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
    J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
    Smith MS; Thresher RJ; Pagano JS
    Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
    Layne SP; Merges MJ; Dembo M; Spouge JL; Conley SR; Moore JP; Raina JL; Renz H; Gelderblom HR; Nara PL
    Virology; 1992 Aug; 189(2):695-714. PubMed ID: 1386485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
    Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IFN alpha on late stages of HIV-1 replication cycle.
    Dianzani F; Castilletti C; Gentile M; Gelderblom HR; Frezza F; Capobianchi MR
    Biochimie; 1998; 80(8-9):745-54. PubMed ID: 9865497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
    Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    McKeating JA; McKnight A; Moore JP
    J Virol; 1991 Feb; 65(2):852-60. PubMed ID: 1898972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of defective HIV-1 particles to replication-competent infectious virions.
    Bourinbaiar AS
    Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
    Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
    J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
    Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
    J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.
    Sato H; Orenstein J; Dimitrov D; Martin M
    Virology; 1992 Feb; 186(2):712-24. PubMed ID: 1370739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.
    Handley MA; Steigbigel RT; Morrison SA
    J Virol; 1996 Jul; 70(7):4451-6. PubMed ID: 8676469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
    Fischer PB; Collin M; Karlsson GB; James W; Butters TD; Davis SJ; Gordon S; Dwek RA; Platt FM
    J Virol; 1995 Sep; 69(9):5791-7. PubMed ID: 7543588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
    Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
    AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    Pandori MW; Fitch NJ; Craig HM; Richman DD; Spina CA; Guatelli JC
    J Virol; 1996 Jul; 70(7):4283-90. PubMed ID: 8676450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
    Lundquist CA; Zhou J; Aiken C
    J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface.
    Okada T; Patterson BK; Ye SQ; Gurney ME
    Virology; 1993 Feb; 192(2):631-42. PubMed ID: 8421903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
    DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
    J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.